CLINICAL_TRIALS
research
· 2007-08-21
Clinical Trial Update: The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome [NA]
Summary
A clinical trial update examining the effect of ProAlgaZyme on HDL cholesterol in people with metabolic syndrome and hyperlipidemia; the trial status is current…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Health Enhancement Products, Inc. | Conditions: Metabolic Syndrome, Hyperlipidemia | NA | Status: UNKNOWN